Inventor · disambiguated record
Maxwell M. Reeve
Also filed as: REEVE MAXWELL · REEVE MAXWELL M · REEVE MAXWELL MARCO
6 granted patents·4 pending applications·20 citations·filing 1991–2025
78Inventor score
Files withARVINAS OPERATIONS INC3MELINTA THERAPEUTICS INC3BRITISH BIO TECHNOLOGY1BRITISH BIOTECH PHARM1FENG JUN1
Top patents by PatentIndex Score
10 records- 0183US8497378B2Process for making quinolone compoundsHANSELMANN ROGER·Filed 2009·Granted Jul 30, 2013·5 cites·22 claims
- 0282US8222411B2Dipeptidyl peptidase inhibitorsFENG JUN·Filed 2006·Granted Jul 17, 2012·8 cites·5 claims
- 0375USRE46617EProcess for making quinolone compoundsMELINTA THERAPEUTICS INC·Filed 2009·Granted Nov 28, 2017·1 cites·22 claims
- 0463US8871938B2Process for making quinolone compoundsMELINTA THERAPEUTICS INC·Filed 2013·Granted Oct 28, 2014·0 cites·22 claims
- 0563US2024409529A1Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the SameARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0654US2024336566A1Crystalline forms of a compound for the targeted degradation of the androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0748US2025282750A1Methods of manufacturing an androgen receptor protein degraderARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 0847US5986132ASynthesis of carboxylic acid derivativesBRITISH BIOTECH PHARM·Filed 1996·Granted Nov 16, 1999·4 cites·6 claims
- 0944US2016046603A1Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-QuinolinecarboxylateMELINTA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1038US5256811ACertain intermediates for the preparation of neuinic acid derivativesBRITISH BIO TECHNOLOGY·Filed 1991·Granted Oct 26, 1993·2 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Maxwell M. Reeve files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →